SGO's Statement on Use of CA125 for Monitoring Ovarian...
SGO's Statement on Use of CA125 for Monitoring Ovarian Cancer
06/08/2009 Last weekend a European study regarding the use of CA 125 testing in ovarian cancer patients was presented at the American Society of Clinical Oncologists (ASCO) Annual Meeting. The … Continued